Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Non-Current Debt (2020 - 2025)

Historic Non-Current Debt for iBio (IBIO) over the last 6 years, with Q2 2025 value amounting to $64000.0.

  • iBio's Non-Current Debt fell 9164.49% to $64000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $64000.0, marking a year-over-year decrease of 9164.49%. This contributed to the annual value of $64000.0 for FY2025, which is 9164.49% down from last year.
  • iBio's Non-Current Debt amounted to $64000.0 in Q2 2025, which was down 9164.49% from $643000.0 recorded in Q4 2024.
  • In the past 5 years, iBio's Non-Current Debt registered a high of $22.1 million during Q1 2022, and its lowest value of $34000.0 during Q1 2021.
  • Moreover, its 5-year median value for Non-Current Debt was $674500.0 (2024), whereas its average is $5.8 million.
  • Its Non-Current Debt has fluctuated over the past 5 years, first soared by 6495882.35% in 2022, then crashed by 9164.49% in 2025.
  • Quarter analysis of 5 years shows iBio's Non-Current Debt stood at $22.1 million in 2021, then rose by 0.3% to $22.1 million in 2022, then crashed by 98.91% to $241000.0 in 2023, then soared by 166.8% to $643000.0 in 2024, then plummeted by 90.05% to $64000.0 in 2025.
  • Its Non-Current Debt was $64000.0 in Q2 2025, compared to $643000.0 in Q4 2024 and $706000.0 in Q3 2024.